the aid library

Modelling the health impacts of disruptions to essential health services during COVID-19

UN Children's Fund UNICEF; Umited Nations Popuilation Fund UNFPA; World Health Organization WHO (2021) C_WHO

- Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition Coronavirus disease 2019 (COVID-19) has a wide range of documented effects. It directly causes death and disability for some people infected. However, disruption to ... more

Integrated Family Planning and Immunization Service Delivery at Health Facility and Community Sites in Dowa and Ntchisi Districts of Malawi: A Mixed Methods Process Evaluation

Cooper, C. M.; Wille, J.; Shire, S.; et al. (2020) CC2

The Government of Malawi’s Health Sector Strategic Plan II highlights the importance of service integration; however, in practice, this has not been fully realized. We conducted a mixed methods evaluation of efforts to systematically implement int ... more

The efects of extreme heat on human health in tropical africa

Kunda J., Gosling S., Foody G. et al. (2024) C2

This review examines high-quality research evidence that synthesises the efects of extreme heat on human health in tropical Africa. Web of Science (WoS) was used to identify research articles on the efects extreme heat, humidity, Wet-bulb Globe Temperature (WBGT), apparent temperature, wind, Heat ... more

The Lancet Commission on lessons for the future from the COVID-19 pandemic

Sachs, J., Karim, S., Aknin, L. et al. The Lancet Commissions (2022) CC

This Commission report aims to contribute to a new era of multilateral cooperation based on strong UN institutions to reduce the dangers of COVID-19, forestall the next pandemic, and enable the world to achieve the agreed goals of sustainable development, human rights, and peace that governments are ... more

SBC Compass Coronavirus Collection

Leibtag, S.; USAID (2020) C1

COVID-19: Tools for Social and Behavior Change Page en français Social and behavior change (SBC) professionals are well positioned to address COVID-19 interventions. We offer two Trending Topics – This one, with Tools for SBC Professionals and another with Materials and Resources for the Publi ... more

Towards a dementia plan: a WHO guide

Freel; S.; K. Seeher; N. Chowdhary, et al. World Health Organization (2018) C_WHO

COVID Reference 2020.4 VNM

Kamps, B.S.; C. Hoffmann, et al. (2020) CC

Tại nhiều quốc gia, cú sốc của làn sóng kiểm dịch thứ nhất đã lắng xuống, số ca bệnh cũng đã giảm, việc gỡ bỏ các lệnh phong tỏa đang được xem xét hoặc đã được thực hiện ở nhiều nơi. Vũ Hán đã mở cửa trở lại. Nhưng ph ... more

COVID Reference 2020.3 DEU
recommended

Kamps, B.S.; and C. Hoffmann (2020) CC

Dengue virus: epidemiology, biology, and disease aetiology

Kumar Roy., S. and S. Bhattacharjee (2021) CC

Canadian Journal of Microbiology 25 June 2021 https://doi.org/10.1139/cjm-2020-0572

COVID Reference 2020.3 FRA

Kamps, B.S.; and C. Hoffmann (2020) CC

La 3ieme édition du nouveau mini-manuel. Au cours des mois à venir COVID Reference publiera des mises à jour régulières.

L'usage problématique d'internet

J. Pei-Chen Chang; C.-C. Hung IACAPAP (2012) C2

Autres troubles Chapitre H.6 Edition en français Traduction : Basile Gonzales Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map

Van Katwyk, S. R.; Grimshaw, J. M.; et al (2019) C2

BACKGROUND: Growing political attention to antimicrobial resistance (AMR) offers a rare opportunity for achieving meaningful action. Many governments have developed national AMR action plans, but most have not yet implemented policy interventions to reduce antimicrobial overuse. A systematic evidenc ... e map can support governments in making evidence-informed decisions about implementing programs to reduce AMR, by identifying, describing, and assessing the full range of evaluated government policy options to reduce antimicrobial use in humans. METHODS AND FINDINGS: Seven databases were searched from inception to January 28, 2019, (MEDLINE, CINAHL, EMBASE, PAIS Index, Cochrane Central Register of Controlled Trials, Web of Science, and PubMed). We identified studies that (1) clearly described a government policy intervention aimed at reducing human antimicrobial use, and (2) applied a quantitative design to measure the impact. We found 69 unique evaluations of government policy interventions carried out across 4 of the 6 WHO regions. These evaluations included randomized controlled trials (n = 4), non-randomized controlled trials (n = 3), controlled before-and-after designs (n = 7), interrupted time series designs (n = 25), uncontrolled before-and-after designs (n = 18), descriptive designs (n = 10), and cohort designs (n = 2). From these we identified 17 unique policy options for governments to reduce the human use of antimicrobials. Many studies evaluated public awareness campaigns (n = 17) and antimicrobial guidelines (n = 13); however, others offered different policy options such as professional regulation, restricted reimbursement, pay for performance, and prescription requirements. Identifying these policies can inform the development of future policies and evaluations in different contexts and health systems. Limitations of our study include the possible omission of unpublished initiatives, and that policies not evaluated with respect to antimicrobial use have not been captured in this review. CONCLUSIONS: To our knowledge this is the first study to provide policy makers with synthesized evidence on specific government policy interventions addressing AMR. In the future, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published. more

COVID Reference 2021.6 ES

Kamps, B.S.; C. Hoffmann, A. Gualani Gualani; and J. Garcia-Rosales Delgado (2021) CC

6a edición clínica. Nuevo: 4. Vacunas (26 de abril); Nuevo: 5. Pruebas y procedimientos de diagnóstico (7 de abril); Nuevo: 7. COVID-19 persistente (7 de abril)

Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19

Kluge, S. et al. Springer Medizin Verlag GmbH (2020) C3

Medizinische KlinikIntensivmedizin und Notfallmedizin https://doi.org/10.1007/s00063-020-00674-3

Pharmaceutical Waste Management: A Review

Rajbongshi, S.; et al. (2016) C1

European Journal of Biomedical and Pharmaceutical Sciences, vol.3 (2016) 1, 192-206 This review shows that if all sub areas of pharmaceutical waste management can efficiently work back to back environmental pollution and dangers to human health can reduce significantly.

COVID Reference 2020.4 POR

Kamps, B.S.; and C. Hoffmann (2019) CC

4ª edição Nos próximos meses, a COVID Reference apresentará atualizações regulares e narrará os dados científicos o mais coerente possível.

COVID Reference 2021.6 EN
recommended

Kamps, B.S.; Camp, R. and C. Hoffmann (2021) CC

Trastorno por déficit de atención con hiperactividad

T. S. Moriyama; A. J. M. Cho; R. E. Verin; et al. IACAPAP (2017) C2

Trastornos externalizantes Capítulo D.1 Edición: Matías Irarrázaval & Andrés Martín Traducción: Fernanda Prieto Tagle, Marta García Acuña

Dementia - Toolkit for community workers in low- and middle-income countries

Mercado, S. World Health Organization (Pacific Region) (2018) C_WHO

Guide for community-based management and care of people with dementia Version 1.0 Mental Health and Substance Abuse Division of NCD and Health through the Life-Course World Health Organization Regional Office for the Western Pacific